pegol

  1. T

    Long-Term Data On Cimzia® (certolizumab Pegol) For Moderate To Severe Crohn's Disease

    Studies and analyses of the Crohn's disease (CD) treatment Cimzia® (certolizumab pegol) will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology, taking place in San Antonio from October 15 - 20. "Cimzia data at this year's ACG meeting continue to...
Back
Top